PHC Holdings (6523) Fundamentals 2026 — P/E 286.2x, Revenue Analysis | SniperIQ
PHC Holdings (6523) is a JP-listed Healthcare company in Medical - Devices with a market capitalization of ¥139.4B, trading at ¥1102.00 on the JPX. This SniperIQ fundamentals page covers PHC Holdings's valuation (P/E 286.2x, P/B 0.9x), profitability (net margin 0.1%), revenue (¥364.4B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PHC Holdings's market cap?
PHC Holdings (6523) has a market capitalization of approximately ¥139.4B, trading at ¥1102.00 on the JPX. Market cap moves with the live share price.
What is PHC Holdings's P/E ratio?
PHC Holdings's trailing twelve-month P/E ratio is 286.2x, with a price-to-book (P/B) of 0.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is PHC Holdings?
PHC Holdings runs a net profit margin of 0.1%, a gross margin of 45.4%, and an operating margin of 5.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PHC Holdings generate?
PHC Holdings reported revenue of ¥364.4B for fiscal year 2025, with net income of ¥492M and earnings per share (EPS) of 3.89. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PHC Holdings pay a dividend?
PHC Holdings offers a trailing dividend yield of about 3.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is PHC Holdings financially healthy?
PHC Holdings carries a debt-to-equity ratio of 1.45x and a current ratio of 0.93x, with a market beta of 0.64. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PHC Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PHC Holdings (6523) the key facts are: market cap ¥139.4B, P/E 286.2x, revenue ¥364.4B, 52-week range 878-1189. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track PHC Holdings's full fundamentals live
Get PHC Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.